Increasing prevalence of dehydration-related conditions,
growing health and wellness trends, and aging population are the
major factors which drive the global market growth.
PORTLAND, Ore., Aug. 13,
2024 /PRNewswire/ -- Allied Market Research published
a report, titled, "Intravenous (IV) Hydration
Therapy Market by Service (Immune boosters, Energy boosters,
Skin care, Migraine and Others), Component (Medicated and
Non-medicated), End user (Hospital & Clinics, Wellness Centers
& Spas, Home Healthcare, and Others) : Global Opportunity
Analysis and Industry Forecast, 2024-2033". According to the
report, the intravenous (IV) hydration therapy market was valued at
$2.3 billion in 2023, and is
estimated to reach $4.9 billion by
2033, growing at a CAGR of 7.8% from 2024 to 2033.
Request Sample of the Report on Intravenous (IV) Hydration
Therapy Market Forecast 2033 -
https://www.alliedmarketresearch.com/request-sample/A323708
Prime determinants of growth
Increasing prevalence of dehydration-related conditions, and
growing health and wellness trends are the major factors that drive
the growth of the intravenous (IV) hydration therapy market growth.
However, high cost and risk of complications hinder the market
growth. Moreover, technological advancements and expanding
healthcare infrastructure in developing economies offers
remunerative opportunities for the expansion of the global
intravenous (IV) hydration therapy market.
Report coverage & details
Report
Coverage
|
Details
|
Forecast
Period
|
2024–2033
|
Base
Year
|
2023
|
Market Size in
2023
|
$2.3
billion
|
Market Size in
2033
|
$4.9
billion
|
CAGR
|
7.8 %
|
No. of Pages in
Report
|
220
|
Segments
Covered
|
Service, Component, End
User and Region.
|
Drivers
|
Increase in prevalence
of dehydration-related conditions
|
|
Growth in health and
wellness trends
|
|
Rise in aging
population
|
Opportunities
|
Technological
advancements
|
|
Increase in healthcare
spending
|
Restraints
|
High
cost
|
|
Risk of
complications
|
For Purchase Related Queries/Inquiry
- https://www.alliedmarketresearch.com/purchase-enquiry/A323708
Segment Highlights
The immune booster service is widely used in the IV hydration
therapy market due to its effectiveness in enhancing the body's
natural defenses. This treatment typically includes a combination
of vitamins, such as Vitamin C and B-Complex, along with essential
minerals and antioxidants. By directly infusing these nutrients
into the bloodstream, the therapy quickly boosts the immune system,
helping to prevent illnesses and accelerate recovery, making it
popular among health-conscious individuals.
In addition, the rise in the use of medicated IV hydration
therapy is fueled by its effectiveness in quickly replenishing
essential nutrients and fluids. This therapy bypasses the digestive
system, delivering vitamins, minerals, and medications directly
into the bloodstream. It's popular among athletes, those seeking
quick recovery from dehydration, and individuals aiming to boost
energy levels or treat specific health conditions. Its convenience
and immediate impact contribute to its growing popularity in
wellness and medical circles.
Have a Question? Connect to our Analyst -
https://www.alliedmarketresearch.com/connect-to-analyst/A323708
Furthermore, the need for IV hydration therapy is prominently
observed in hospitals and clinics where patients require rapid
rehydration due to conditions such as severe dehydration,
electrolyte imbalances, or inability to take fluids orally. IV
therapy allows healthcare providers to deliver fluids,
electrolytes, and medications directly into the bloodstream,
ensuring efficient absorption and swift relief of symptoms. Its
controlled administration and ability to address critical medical
needs make it a cornerstone in clinical settings for managing
various health challenges.
Regional Outlook
The IV hydration therapy market varies regionally. North America leads due to high health
awareness, advanced healthcare, and disposable income. Europe follows with growing wellness tourism
and dehydration treatment. The Asia-Pacific region is rapidly expanding due
to rising health awareness and better healthcare access.
Latin America and the Middle East are also growing, driven by
improved healthcare and medical tourism, despite regulatory
challenges and higher costs.
Key Players
- Davita
- Nikkiso Co. Ltd.
- Core IV Therapy, LLC
- Cryojuvenate UK Ltd.
- B. Braun Medical Inc.
- Otsuka Pharmaceutical Co., Ltd.
- NexGen Health
- JW Life Science Corporation
- Amanta Healthcare
- Baxter International Inc.
- Drip Hydration
The report provides a detailed analysis of these key players in
the global intravenous (IV) hydration therapy market. These players
have adopted different strategies such as expansion, product
approval, product launch and others to increase their market share
and maintain dominant shares in different regions. The report is
valuable in highlighting business performance, operating segments,
product portfolio, and strategic moves of market players to
showcase the competitive scenario.
Recent Industry Development
- In December 2022, The DRIPBaR, an
IV vitamin therapy franchise growing rapidly across America,
announced that they have partnered with entrepreneur, investor, and
original "Shark Tank" shark, Kevin
Harrington. Providing cells with the nutritional "fuel"
through IV therapy, the franchise is experiencing tremendous annual
growth as well as rapidly expanding across the nation.
- In September 2021, B. Braun
Medical Inc. (B. Braun), a leader in infusion therapy and pain
management, announced the launch of its new CARESAFE IV
Administration Sets with Optional AirStop component. CARESAFE IV
Sets are the first robust portfolio of IV administration sets in
the U.S. market that are not made with polyvinyl chloride (PVC) and
diethylhexyl phthalate (DEHP).
- In September 2022, ScreenPro
Security Inc. announced that its wholly owned subsidiary
Concierge Medical Consultants Inc. has introduced Intravenous
Vitamin Therapy (IV Therapy) to its services in Toronto and Vancouver.
AVENUE- A Subscription-Based Library (Premium on-demand,
subscription-based pricing model) Offered by Allied Market
Research:
AMR introduces its online premium subscription-based library
Avenue, designed specifically to offer cost-effective, one-stop
solution for enterprises, investors, and universities. With Avenue,
subscribers can avail an entire repository of reports on more than
2,000 niche industries and more than 12,000 company profiles.
Moreover, users can get an online access to quantitative and
qualitative data in PDF and Excel formats along with analyst
support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any
device and anywhere. For more details, follow the link:
https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research
and business-consulting wing of Allied Analytics LLP based in
Wilmington, Delaware. Allied
Market Research provides global enterprises as well as medium and
small businesses with unmatched quality of "Market Research
Reports" and "Business Intelligence Solutions." AMR has a targeted
view to provide business insights and consulting to assist its
clients to make strategic business decisions and achieve
sustainable growth in their respective market domains. AMR offers
its services across 11 industry verticals including Life Sciences,
Consumer Goods, Materials & Chemicals, Construction &
Manufacturing, Food & Beverages, Energy & Power,
Semiconductor & Electronics, Automotive & Transportation,
ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various
companies and this helps us in digging out market data that helps
us generate accurate research data tables and confirms utmost
accuracy in our market forecasting. Allied Market Research CEO
Pawan Kumar is instrumental in
inspiring and encouraging everyone associated with the company to
maintain high quality of data and help clients in every way
possible to achieve success. Each and every data presented in the
reports published by us is extracted through primary interviews
with top officials from leading companies of domain concerned. Our
secondary data procurement methodology includes deep online and
offline research and discussion with knowledgeable professionals
and analysts in the industry.
Contact
David Correa
1209 Orange
Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l:
+1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
Logo:
https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/intravenous-iv-hydration-therapy-market-to-reach-4-9-billion-globally-by-2033-at-7-8-cagr-allied-market-research-302220882.html
SOURCE Allied Market Research